The Latest Breaking News from Abbott

Lupron, a drug patented half a century ago, treats advanced prostate cancer. It costs a few hundred dollars in the U.K. — so why are U.S. hospitals charging so much more to administer it?

Stocks jumped Monday, but soon hit resistance amid surging Treasury yields. Tesla hit lows on earnings while Netflix jumped.

Abbott Laboratories is building a new infant-formula manufacturing plant after the product shortage of the past year revealed gaps in U.S. production capacity.

Abbott enjoyed a third-quarter beat thanks, in part, to its Covid tests. But those sales are expected to peter out, and ABT stock slumped.

The recall, issued on Oct. 14, includes the brands Similac and Pedialyte Electrolyte Solution

Holley’s mission is to bring awareness to all disabilities with the message, “Our Ability is STRONGER than our dis-Ability.”

Select Similac products are part of a new recall from Abbott Nutrition.

Several months after the US government began investigating an Abbott Laboratories baby-formula plant for its connection to the deaths of at least two infants, the world’s most influential judge of corporate environmental, social and governance practices upgraded the company.

The 65-year-old mega-talent has been criminally underappreciated until now – ‘Isn’t it such a blessing that I could remain relevant after all of these years?’

The Food and Drug Administration rattled off 15 reasons behind the national baby formula shortage, but couldn't identify a specific person or agency responsible.

U.S. health regulators say their response to the ongoing infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory